2015 - NANETS https://nanets.net/abstracts-archive/2015?format=html Thu, 15 Feb 2018 13:31:20 -0500 en-GB hourly 1 C52 – Clinical and Immunohistochemical Features of Non-Pancreatic Gastrointestinal Neuroendocrine Neoplasms https://nanets.net/abstracts-archive/2015/410-c52-clinical-and-immunohistochemical-features-of-non-pancreatic-gastrointestinal-neuroendocrine-neoplasms?format=html C52 – Clinical and Immunohistochemical Features of Non-Pancreatic Gastrointestinal Neuroendocrine Neoplasms Zemek, DiMaio, Allen, Vairamuthu, Balise, Longacre, Kunz

]]> https://nanets.net/abstracts-archive/2015/410-c52-clinical-and-immunohistochemical-features-of-non-pancreatic-gastrointestinal-neuroendocrine-neoplasms?format=html Zemek, DiMaio, Allen, Vairamuthu, Balise, Longacre, Kunz

]]> support@adgcommunications.com (Super User) 2015 Thu, 15 Feb 2018 13:31:20 -0500 C50 – Predicting Post-Therapy Response Using Computational Image Analysisn https://nanets.net/abstracts-archive/2015/408-c50-predicting-post-therapy-response-using-computational-image-analysisn?format=html C50 – Predicting Post-Therapy Response Using Computational Image Analysisn Wu, Moss, Hasan, Kunz, Nosher, Foran

]]> https://nanets.net/abstracts-archive/2015/408-c50-predicting-post-therapy-response-using-computational-image-analysisn?format=html Wu, Moss, Hasan, Kunz, Nosher, Foran

]]> support@adgcommunications.com (Super User) 2015 Thu, 15 Feb 2018 13:31:19 -0500 C51 – Safety and Efficacy of Everolimus in Advanced Nonfunctional Neuroendocrine Tumors (NET) of Lung or Gastrointestinal (GI) Origin: Findings of the Randomized, Placebo-Controlled, Double-blind, Multicenter, Phase 3 RADIANT-4 Study https://nanets.net/abstracts-archive/2015/409-c51-safety-and-efficacy-of-everolimus-in-advanced-nonfunctional-neuroendocrine-tumors-net-of-lung-or-gastrointestinal-gi-origin-findings-of-the-randomized-placebo-controlled-double-blind-multicenter-phase-3-radiant-4-study?format=html C51 – Safety and Efficacy of Everolimus in Advanced Nonfunctional Neuroendocrine Tumors (NET) of Lung or Gastrointestinal (GI) Origin: Findings of the Randomized, Placebo-Controlled, Double-blind, Multicenter, Phase 3 RADIANT-4 Study James C. Yao; Nicola Fazio; Simron Singh; Roberto Buzzoni; Carlo Carnaghi; Edward Wolin; Jiri Tomasek; Markus Raderer; Harald Lahner; Maurizio Voi; Lida Pacaud; Nicolas Rouyrre; Carolin Sachs; Juan Valle; Gianfranco Delle Fave; Eric Van Cutsem; M.E.T. Tesselaar; Yasuhiro Shimada; Do-Youn Oh; Jonathan Strosberg; Matthew H. Kulke; Marianne E. Pavel

]]> https://nanets.net/abstracts-archive/2015/409-c51-safety-and-efficacy-of-everolimus-in-advanced-nonfunctional-neuroendocrine-tumors-net-of-lung-or-gastrointestinal-gi-origin-findings-of-the-randomized-placebo-controlled-double-blind-multicenter-phase-3-radiant-4-study?format=html James C. Yao; Nicola Fazio; Simron Singh; Roberto Buzzoni; Carlo Carnaghi; Edward Wolin; Jiri Tomasek; Markus Raderer; Harald Lahner; Maurizio Voi; Lida Pacaud; Nicolas Rouyrre; Carolin Sachs; Juan Valle; Gianfranco Delle Fave; Eric Van Cutsem; M.E.T. Tesselaar; Yasuhiro Shimada; Do-Youn Oh; Jonathan Strosberg; Matthew H. Kulke; Marianne E. Pavel

]]> support@adgcommunications.com (Super User) 2015 Thu, 15 Feb 2018 13:31:19 -0500 C49 – Incidence of Nodal Positivity in Appendiceal Neuroendocrine Tumors (NETs) and Its Effect on Survival https://nanets.net/abstracts-archive/2015/407-c49-incidence-of-nodal-positivity-in-appendiceal-neuroendocrine-tumors-nets-and-its-effect-on-survival?format=html C49 – Incidence of Nodal Positivity in Appendiceal Neuroendocrine Tumors (NETs) and Its Effect on Survival Woltering, Beyer, Thiagarajan, Wang, Ramirez, Boudreaux

 Download Poster

]]> https://nanets.net/abstracts-archive/2015/407-c49-incidence-of-nodal-positivity-in-appendiceal-neuroendocrine-tumors-nets-and-its-effect-on-survival?format=html Woltering, Beyer, Thiagarajan, Wang, Ramirez, Boudreaux

 Download Poster

]]> support@adgcommunications.com (Super User) 2015 Thu, 15 Feb 2018 13:31:18 -0500 C48 – Multivariate Analysis of Progression-Free Survival in the CLARINET Study of Lanreotide Autogel/Depot vs Placebo Identifies Prognostic Factors in Neuroendocrine Tumors https://nanets.net/abstracts-archive/2015/406-c48-multivariate-analysis-of-progression-free-survival-in-the-clarinet-study-of-lanreotide-autogel-depot-vs-placebo-identifies-prognostic-factors-in-neuroendocrine-tumors?format=html C48 – Multivariate Analysis of Progression-Free Survival in the CLARINET Study of Lanreotide Autogel/Depot vs Placebo Identifies Prognostic Factors in Neuroendocrine Tumors Wolin, Caplin, Pavel, Ćwikła, Phan, Raderer, Sedláĉková, Cadiot, Capdevila, Wall, Rindi, Langley, Gomez-Panzani, Ruszniewski

 Download Poster

]]> https://nanets.net/abstracts-archive/2015/406-c48-multivariate-analysis-of-progression-free-survival-in-the-clarinet-study-of-lanreotide-autogel-depot-vs-placebo-identifies-prognostic-factors-in-neuroendocrine-tumors?format=html Wolin, Caplin, Pavel, Ćwikła, Phan, Raderer, Sedláĉková, Cadiot, Capdevila, Wall, Rindi, Langley, Gomez-Panzani, Ruszniewski

 Download Poster

]]> support@adgcommunications.com (Super User) 2015 Thu, 15 Feb 2018 13:31:17 -0500 C47 – Lung Neuroendocrine Tumor (NET) US Patient-Reported Experience: Results from the First Global NET Patient Survey - A Collaboration Between the International Neuroendocrine Cancer Alliance (INCA) and Novartis https://nanets.net/abstracts-archive/2015/405-c47-lung-neuroendocrine-tumor-net-us-patient-reported-experience-results-from-the-first-global-net-patient-survey-a-collaboration-between-the-international-neuroendocrine-cancer-alliance-inca-and-novartis?format=html C47 – Lung Neuroendocrine Tumor (NET) US Patient-Reported Experience: Results from the First Global NET Patient Survey - A Collaboration Between the International Neuroendocrine Cancer Alliance (INCA) and Novartis Wolin, Sissons, Goldstein, Leyden, Kolarova

 Download Poster

]]> https://nanets.net/abstracts-archive/2015/405-c47-lung-neuroendocrine-tumor-net-us-patient-reported-experience-results-from-the-first-global-net-patient-survey-a-collaboration-between-the-international-neuroendocrine-cancer-alliance-inca-and-novartis?format=html Wolin, Sissons, Goldstein, Leyden, Kolarova

 Download Poster

]]> support@adgcommunications.com (Super User) 2015 Thu, 15 Feb 2018 13:31:16 -0500 C45 – Is Surgical Cytoreduction for Stage IV Pancreatic Neuroendocrine Tumors Justifiable? https://nanets.net/abstracts-archive/2015/403-c45-is-surgical-cytoreduction-for-stage-iv-pancreatic-neuroendocrine-tumors-justifiable?format=html C45 – Is Surgical Cytoreduction for Stage IV Pancreatic Neuroendocrine Tumors Justifiable? Wang, McCord, Stevens, Diebold, Ramirez, Boudreaux, Woltering

 Download Poster

]]> https://nanets.net/abstracts-archive/2015/403-c45-is-surgical-cytoreduction-for-stage-iv-pancreatic-neuroendocrine-tumors-justifiable?format=html Wang, McCord, Stevens, Diebold, Ramirez, Boudreaux, Woltering

 Download Poster

]]> support@adgcommunications.com (Super User) 2015 Thu, 15 Feb 2018 13:31:15 -0500 C46 – Lanreotide Depot/Autogel in Intestinal and Pancreatic Neuroendocrine Tumors According to Body Mass Index: Subgroup Analyses from the CLARINET Study https://nanets.net/abstracts-archive/2015/404-c46-lanreotide-depot-autogel-in-intestinal-and-pancreatic-neuroendocrine-tumors-according-to-body-mass-index-subgroup-analyses-from-the-clarinet-study?format=html C46 – Lanreotide Depot/Autogel in Intestinal and Pancreatic Neuroendocrine Tumors According to Body Mass Index: Subgroup Analyses from the CLARINET Study Wolin, Caplin, Pavel, Ćwikła, Phan, Raderer, Sedláĉková, Cadiot, Capdevila, Wall, Rindi, Langley, Gomez-Panzani, Ruszniewski

 Download Poster

]]> https://nanets.net/abstracts-archive/2015/404-c46-lanreotide-depot-autogel-in-intestinal-and-pancreatic-neuroendocrine-tumors-according-to-body-mass-index-subgroup-analyses-from-the-clarinet-study?format=html Wolin, Caplin, Pavel, Ćwikła, Phan, Raderer, Sedláĉková, Cadiot, Capdevila, Wall, Rindi, Langley, Gomez-Panzani, Ruszniewski

 Download Poster

]]> support@adgcommunications.com (Super User) 2015 Thu, 15 Feb 2018 13:31:15 -0500 C44 – Does the Addition of Adjuvant Intraoperative Post-Dissection Tumor Bed Chemotherapy During GI Neuroendocrine Tumor Debulking Benefit Patients? https://nanets.net/abstracts-archive/2015/402-c44-does-the-addition-of-adjuvant-intraoperative-post-dissection-tumor-bed-chemotherapy-during-gi-neuroendocrine-tumor-debulking-benefit-patients?format=html C44 – Does the Addition of Adjuvant Intraoperative Post-Dissection Tumor Bed Chemotherapy During GI Neuroendocrine Tumor Debulking Benefit Patients? Wang, Chauhan, Ramirez, Beyer, Stevens, Woltering, Boudreaux

]]> https://nanets.net/abstracts-archive/2015/402-c44-does-the-addition-of-adjuvant-intraoperative-post-dissection-tumor-bed-chemotherapy-during-gi-neuroendocrine-tumor-debulking-benefit-patients?format=html Wang, Chauhan, Ramirez, Beyer, Stevens, Woltering, Boudreaux

]]> support@adgcommunications.com (Super User) 2015 Thu, 15 Feb 2018 13:31:14 -0500 C43 – Neuroendocrine Tumor of the Appendix in Children https://nanets.net/abstracts-archive/2015/401-c43-neuroendocrine-tumor-of-the-appendix-in-children?format=html C43 – Neuroendocrine Tumor of the Appendix in Children Venkatramani, Wu, Chintagumpala

 Download Poster

]]> https://nanets.net/abstracts-archive/2015/401-c43-neuroendocrine-tumor-of-the-appendix-in-children?format=html Venkatramani, Wu, Chintagumpala

 Download Poster

]]> support@adgcommunications.com (Super User) 2015 Thu, 15 Feb 2018 13:31:13 -0500 C42 – Recurrence Patterns Following Surgical Resection of Gastroenteropancreatic Neuroendocrine Tumors: An Analysis from the NCCN Oncology Outcomes Database https://nanets.net/abstracts-archive/2015/400-c42-recurrence-patterns-following-surgical-resection-of-gastroenteropancreatic-neuroendocrine-tumors-an-analysis-from-the-nccn-oncology-outcomes-database?format=html C42 – Recurrence Patterns Following Surgical Resection of Gastroenteropancreatic Neuroendocrine Tumors: An Analysis from the NCCN Oncology Outcomes Database Van Loon, Zhang, Creasman, Bobiak, Zornosa, Choti, Kulke, Yao, Nakakura, Bloomston, Benson, Shah, Strosberg, Bergsland

 Download Poster

]]> https://nanets.net/abstracts-archive/2015/400-c42-recurrence-patterns-following-surgical-resection-of-gastroenteropancreatic-neuroendocrine-tumors-an-analysis-from-the-nccn-oncology-outcomes-database?format=html Van Loon, Zhang, Creasman, Bobiak, Zornosa, Choti, Kulke, Yao, Nakakura, Bloomston, Benson, Shah, Strosberg, Bergsland

 Download Poster

]]> support@adgcommunications.com (Super User) 2015 Thu, 15 Feb 2018 13:31:12 -0500 C41 – Patterns and Sequencing of Systemic Therapies in Patients with Advanced Neuroendocrine Tumors (NET) https://nanets.net/abstracts-archive/2015/399-c41-patterns-and-sequencing-of-systemic-therapies-in-patients-with-advanced-neuroendocrine-tumors-net?format=html C41 – Patterns and Sequencing of Systemic Therapies in Patients with Advanced Neuroendocrine Tumors (NET) Ter-Minassian, Brooks, Brais, Chan, Christiani, Lin, Gabriel, Dinet, Kulke

]]> https://nanets.net/abstracts-archive/2015/399-c41-patterns-and-sequencing-of-systemic-therapies-in-patients-with-advanced-neuroendocrine-tumors-net?format=html Ter-Minassian, Brooks, Brais, Chan, Christiani, Lin, Gabriel, Dinet, Kulke

]]> support@adgcommunications.com (Super User) 2015 Thu, 15 Feb 2018 13:31:11 -0500 C39 – 177- Lu- Dotatate Significantly Improves Progression- Free Survival in Patients with Midgut Neuroendocrine Tumors: Results of the Phase III NETTER- 1 Trial https://nanets.net/abstracts-archive/2015/397-c39-177-lu-dotatate-significantly-improves-progression-free-survival-in-patients-with-midgut-neuroendocrine-tumors-results-of-the-phase-iii-netter-1-trial?format=html C39 – 177- Lu- Dotatate Significantly Improves Progression- Free Survival in Patients with Midgut Neuroendocrine Tumors: Results of the Phase III NETTER- 1 Trial Strosberg; Wolin; Chasen; Kulke; Bushnell; Caplin; Baum; Mittra; Hobday; Hendifar; Oberg; Sierra; Kwekkeboom; Ruszniewsk; Krenning

 Download Poster

]]> https://nanets.net/abstracts-archive/2015/397-c39-177-lu-dotatate-significantly-improves-progression-free-survival-in-patients-with-midgut-neuroendocrine-tumors-results-of-the-phase-iii-netter-1-trial?format=html Strosberg; Wolin; Chasen; Kulke; Bushnell; Caplin; Baum; Mittra; Hobday; Hendifar; Oberg; Sierra; Kwekkeboom; Ruszniewsk; Krenning

 Download Poster

]]> support@adgcommunications.com (Super User) 2015 Thu, 15 Feb 2018 13:31:10 -0500 C40 – Association of Progression- Free Survival with Overall in Patients with Neuroendocrine Tumor Treated with Somatostatin Analogs https://nanets.net/abstracts-archive/2015/398-c40-association-of-progression-free-survival-with-overall-in-patients-with-neuroendocrine-tumor-treated-with-somatostatin-analogs?format=html C40 – Association of Progression- Free Survival with Overall in Patients with Neuroendocrine Tumor Treated with Somatostatin Analogs Ter-Minassian, Brooks, Brais, Chan, Christiani, Lin, Gabriel, Dinet, Kulke

]]> https://nanets.net/abstracts-archive/2015/398-c40-association-of-progression-free-survival-with-overall-in-patients-with-neuroendocrine-tumor-treated-with-somatostatin-analogs?format=html Ter-Minassian, Brooks, Brais, Chan, Christiani, Lin, Gabriel, Dinet, Kulke

]]> support@adgcommunications.com (Super User) 2015 Thu, 15 Feb 2018 13:31:10 -0500 C38 – Clinical and Pathologic Characteristics of Gastric Neuroendocrine Tumors in a Tertiary Care Center https://nanets.net/abstracts-archive/2015/396-c38-clinical-and-pathologic-characteristics-of-gastric-neuroendocrine-tumors-in-a-tertiary-care-center?format=html C38 – Clinical and Pathologic Characteristics of Gastric Neuroendocrine Tumors in a Tertiary Care Center Stashek; Roses; Furth; Metz

]]> https://nanets.net/abstracts-archive/2015/396-c38-clinical-and-pathologic-characteristics-of-gastric-neuroendocrine-tumors-in-a-tertiary-care-center?format=html Stashek; Roses; Furth; Metz

]]> support@adgcommunications.com (Super User) 2015 Thu, 15 Feb 2018 13:31:09 -0500 C37 – Feasibility of Combining Capecitabine and Temozolomide with yttrium 90 radioembolization (CapTemY90) for Intermediate- Grade Metastatic Neuroendocrine Tumors https://nanets.net/abstracts-archive/2015/395-c37-feasibility-of-combining-capecitabine-and-temozolomide-with-yttrium-90-radioembolization-captemy90-for-intermediate-grade-metastatic-neuroendocrine-tumors?format=html C37 – Feasibility of Combining Capecitabine and Temozolomide with yttrium 90 radioembolization (CapTemY90) for Intermediate- Grade Metastatic Neuroendocrine Tumors Soulen; Soulen; Tietelbaum; Metz; Mondschein; Giantonio; Stavropoulos, Evans; Damjanov

]]> https://nanets.net/abstracts-archive/2015/395-c37-feasibility-of-combining-capecitabine-and-temozolomide-with-yttrium-90-radioembolization-captemy90-for-intermediate-grade-metastatic-neuroendocrine-tumors?format=html Soulen; Soulen; Tietelbaum; Metz; Mondschein; Giantonio; Stavropoulos, Evans; Damjanov

]]> support@adgcommunications.com (Super User) 2015 Thu, 15 Feb 2018 13:31:08 -0500 C36 – Functional Status and Resource Utilization of Elderly Patients with Neuroendocrine Tumors https://nanets.net/abstracts-archive/2015/394-c36-functional-status-and-resource-utilization-of-elderly-patients-with-neuroendocrine-tumors?format=html C36 – Functional Status and Resource Utilization of Elderly Patients with Neuroendocrine Tumors Shih; Shen; Xu; Yao

]]> https://nanets.net/abstracts-archive/2015/394-c36-functional-status-and-resource-utilization-of-elderly-patients-with-neuroendocrine-tumors?format=html Shih; Shen; Xu; Yao

]]> support@adgcommunications.com (Super User) 2015 Thu, 15 Feb 2018 13:31:07 -0500 C35 – 68Ga- DOTATOC PET/CT Effectiveness for Diagnosis and Staging in Neuroendocrine Tumors in Comparison with Octreoscan and High- Resolution, Contrast- Enhanced CT https://nanets.net/abstracts-archive/2015/393-c35-68ga-dotatoc-pet-ct-effectiveness-for-diagnosis-and-staging-in-neuroendocrine-tumors-in-comparison-with-octreoscan-and-high-resolution-contrast-enhanced-ct?format=html C35 – 68Ga- DOTATOC PET/CT Effectiveness for Diagnosis and Staging in Neuroendocrine Tumors in Comparison with Octreoscan and High- Resolution, Contrast- Enhanced CT Shafer; O'Dorisio; Menda; Dillon; Dick; Zamba; O Dorisio

]]> https://nanets.net/abstracts-archive/2015/393-c35-68ga-dotatoc-pet-ct-effectiveness-for-diagnosis-and-staging-in-neuroendocrine-tumors-in-comparison-with-octreoscan-and-high-resolution-contrast-enhanced-ct?format=html Shafer; O'Dorisio; Menda; Dillon; Dick; Zamba; O Dorisio

]]> support@adgcommunications.com (Super User) 2015 Thu, 15 Feb 2018 13:31:06 -0500 C34 – Surgical Resection of the Primary Tumor in Patients with Metastatic Pheochrocytoma and Sympathetic Paraganglioma: Impact on Survival and Quality of Life https://nanets.net/abstracts-archive/2015/392-c34-surgical-resection-of-the-primary-tumor-in-patients-with-metastatic-pheochrocytoma-and-sympathetic-paraganglioma-impact-on-survival-and-quality-of-life?format=html C34 – Surgical Resection of the Primary Tumor in Patients with Metastatic Pheochrocytoma and Sympathetic Paraganglioma: Impact on Survival and Quality of Life Roman Gonzalez; Ayala Ramirez; Christakis; Qui; Waguespack; Habra; Perrier; Jimenez

]]> https://nanets.net/abstracts-archive/2015/392-c34-surgical-resection-of-the-primary-tumor-in-patients-with-metastatic-pheochrocytoma-and-sympathetic-paraganglioma-impact-on-survival-and-quality-of-life?format=html Roman Gonzalez; Ayala Ramirez; Christakis; Qui; Waguespack; Habra; Perrier; Jimenez

]]> support@adgcommunications.com (Super User) 2015 Thu, 15 Feb 2018 13:31:05 -0500 C32 – The Role of Capecitabine/ Temozolomide (CAPTEM) in Metastatic Neuroendocrine Tumors: A Neuroendocrine Tumor Program Experience https://nanets.net/abstracts-archive/2015/390-c32-the-role-of-capecitabine-temozolomide-captem-in-metastatic-neuroendocrine-tumors-a-neuroendocrine-tumor-program-experience?format=html C32 – The Role of Capecitabine/ Temozolomide (CAPTEM) in Metastatic Neuroendocrine Tumors: A Neuroendocrine Tumor Program Experience Ramirez; Chauhan; Beyer; Boudreaux; Wang; Woltering

 Download Poster

]]> https://nanets.net/abstracts-archive/2015/390-c32-the-role-of-capecitabine-temozolomide-captem-in-metastatic-neuroendocrine-tumors-a-neuroendocrine-tumor-program-experience?format=html Ramirez; Chauhan; Beyer; Boudreaux; Wang; Woltering

 Download Poster

]]> support@adgcommunications.com (Super User) 2015 Thu, 15 Feb 2018 13:31:04 -0500